Tracer library / [177Lu]Lu-177-OncoFAP-23

[177Lu]Lu-177-OncoFAP-23

Also written as Lu-177-OncoFAP-23

Radionuclide: Lu-177 t½ 9584.6 min
Modality: Therapy
Production route: —
Stage: Preclinical
Syntheses indexed: 0

Dosimetry and biodistribution studies Fibroblast activation / tumour stroma FAP-directed radioligand therapy

What it is

Compound class: Multivalent (trimeric) FAP-targeted small-molecule radioligand
Target / mechanism: Fibroblast activation protein (FAP) PMID 39266289
Clinical application: FAP-positive solid tumors PMID 39266289
Theranostic pair: —

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [177Lu]Lu-177-OncoFAP-23, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Stage set/updated at stage 39 from PMID 39266289: 'Preclinical Evaluation of 177Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors.'.